A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)

A Study of Telitacicept in Lupus Nephritis

NCT05680480 ·Status: RECRUITING ·Phase: PHASE2

A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

NCT07053137 ·Status: ACTIVE_NOT_RECRUITING

Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus

NCT06137053 ·Status: RECRUITING

Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

NCT06394063 ·Status: RECRUITING ·Phase: NA

Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)

NCT06458972 ·Status: RECRUITING

Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia

NCT05929248 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus

NCT00657189 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

NCT02908100 ·Status: COMPLETED ·Phase: PHASE2

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

NCT07069972 ·Status: NOT_YET_RECRUITING

Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients

NCT05666336 ·Status: RECRUITING ·Phase: PHASE4

ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)

NCT02955615 ·Status: COMPLETED ·Phase: PHASE2

Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus

NCT06297408 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus

NCT01438489 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

NCT02725515 ·Status: COMPLETED ·Phase: PHASE2

A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus

NCT06857214 ·Status: RECRUITING ·Phase: PHASE1

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)

NCT02633163 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

NCT00979654 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

NCT00137969 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus

NCT06535412 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

NCT05531565 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Rituximab Objective Outcome Measures Trial in SLE

NCT03054259 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus

NCT01283139 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

NCT03252587 ·Status: COMPLETED ·Phase: PHASE2

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

NCT06559163 ·Status: RECRUITING ·Phase: PHASE2

An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults

NCT01753193 ·Status: COMPLETED ·Phase: PHASE2